Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Polytrim vs Moxifloxacin for Conjunctivitis
NCT00581542Phase 4Completed
- Sponsor
- University of Rochester
- Start
- Mar 2007
- Primary completion
- Mar 2009
- Modality
- Antimicrobial Peptides, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of trimethoprim + polymyxin B and moxifloxacin in bacterial conjunctivitis (BC) (2 arms), sponsored by University of Rochester. Primary endpoint: Number of Participants With Normal Physical Examination of the Eye at 10 days. Started Mar 2007; status: completed.
02
Drugs
trimethoprim + polymyxin Bmoxifloxacin
03
Conditions
bacterial conjunctivitis (BC)
Beyond the preview
Go deeper on NCT00581542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00581542.